These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased drug cytotoxicity at reduced pH counteracts cyclophosphamide resistance in cultured rat mammary carcinoma cells. Jähde E; Glüsenkamp KH; Rajewsky MF Int J Cancer; 1989 Dec; 44(6):1082-7. PubMed ID: 2606575 [TBL] [Abstract][Full Text] [Related]
4. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Vukovic V; Tannock IF Br J Cancer; 1997; 75(8):1167-72. PubMed ID: 9099966 [TBL] [Abstract][Full Text] [Related]
5. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Jähde E; Glüsenkamp KH; Klünder I; Hülser DF; Tietze LF; Rajewsky MF Cancer Res; 1989 Jun; 49(11):2965-72. PubMed ID: 2720657 [TBL] [Abstract][Full Text] [Related]
7. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone. Raghunand N; Mahoney B; van Sluis R; Baggett B; Gillies RJ Neoplasia; 2001; 3(3):227-35. PubMed ID: 11494116 [TBL] [Abstract][Full Text] [Related]
8. Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. Karuri AR; Dobrowsky E; Tannock IF Br J Cancer; 1993 Dec; 68(6):1080-7. PubMed ID: 8260358 [TBL] [Abstract][Full Text] [Related]
9. Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. Newell KJ; Tannock IF Cancer Res; 1989 Aug; 49(16):4477-82. PubMed ID: 2743336 [TBL] [Abstract][Full Text] [Related]
10. Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Laurencot CM; Kennedy KA Oncol Res; 1995; 7(7-8):371-9. PubMed ID: 8747600 [TBL] [Abstract][Full Text] [Related]
11. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Diah SK; Smitherman PK; Aldridge J; Volk EL; Schneider E; Townsend AJ; Morrow CS Cancer Res; 2001 Jul; 61(14):5461-7. PubMed ID: 11454692 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient. Kozin SV; Gerweck LE Br J Cancer; 1998 May; 77(10):1580-5. PubMed ID: 9635832 [TBL] [Abstract][Full Text] [Related]
13. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay]. Kurbacher CM; Brenne U; Kurbacher JA; Mallmann P; Krebs D Zentralbl Gynakol; 1996; 118(5):271-8. PubMed ID: 8701623 [TBL] [Abstract][Full Text] [Related]
15. Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drugs. Tietze LF; Neumann M; Möllers T; Fischer R; Glüsenkamp KH; Rajewsky MF; Jähde E Cancer Res; 1989 Aug; 49(15):4179-84. PubMed ID: 2743306 [TBL] [Abstract][Full Text] [Related]
16. Effect of hyperthermia on the sensitivity of human colon carcinoma cells to mitoxantrone. Wang BS; Lumanglas AL; Silva J; Ruszala-Mallon VM; Durr FE Cancer Treat Rep; 1987 Sep; 71(9):831-6. PubMed ID: 3621216 [TBL] [Abstract][Full Text] [Related]
17. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
18. Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells. Satyamoorthy K; Chitnis MP; Pradhan SG; Advani SH Oncology; 1989; 46(2):128-31. PubMed ID: 2710477 [TBL] [Abstract][Full Text] [Related]
19. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965 [TBL] [Abstract][Full Text] [Related]
20. Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations. Yang CJ; Horton JK; Cowan KH; Schneider E Cancer Res; 1995 Sep; 55(18):4004-9. PubMed ID: 7664272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]